Change of Director's Interest Notice - C Jones
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
Bannerman Resources Limited
ABN
34 113 017 128
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Clive Jones
Date of last notice
21 December 2015
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Securities held by Clive Jones as trustee for
the Alyse Investment Trust, a trust in which Mr
Jones has a relevant interest.
Note: Provide details of the circumstances giving rise to the
relevant interest.
Date of change
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
31 December 2015
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held prior to change
Indirect:
Widerange Corporation Pty Ltd
15,495,401 Fully Paid Ordinary Shares
Clive Jones <The Alyse Investment Trust>
1,126,000 Non-Executive Director Options
(Unlisted) exercisable at A$0.072
per
share
and
expiring
21 November 2016
916,100
Class
Non-Executive Director Options
(Unlisted) exercisable at A$0.089
per
share
and
expiring
15 November 2017
Fully Paid Ordinary Shares
Number acquired
61,712,267
Number disposed
Nil
Value/Consideration
Shares issued to Mr Clive Jones as satisfaction
for the part-consideration for the remaining
20% interest in the Company’s Etango Project.
Note: If consideration is non-cash, provide details and estimated
valuation
As the shares are not being issued for cash
consideration, the issue price cannot be
identified. However, the Company has applied
a notional issue price of $0.0474 per share,
being the issue price under the concurrent
Placement to RCF VI.
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held after change
Indirect:
Widerange Corporation Pty Ltd
15,495,401 Fully Paid Ordinary Shares
Clive Jones <The Alyse Investment Trust>
61,712,267 Fully Paid Ordinary Shares
1,126,000 Non-Executive Director Options
(Unlisted) exercisable at A$0.072
per
share
and
expiring
21 November 2016
916,100
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan,
participation in buy-back
Non-Executive Director Options
(Unlisted) exercisable at A$0.089
per
share
and
expiring
15 November 2017
Shares issued to Mr Clive Jones as satisfaction
for the part-consideration for the remaining
20% interest in the Company’s Etango Project.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y
Change of Director’s Interest Notice
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?
Date of this Notice: 31 December 2015
+ See chapter 19 for defined terms.
Appendix 3Y Page 4
01/01/2011
Share your feedback
Discover